Roche
ROG.SW
$315.17
Share price
-0.74%
Change (1 day)
-14.40%
Change (1 year)
Categories
Market capitalization of Roche (ROG.SW)
Market cap: $258.93 Billion
As of September 2022 Roche has a market cap of $258.93 Billion. This makes Roche the world's 26th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Roche from 2006 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $258.93 B | -28% |
| 2021 | $359.63 B | 20.2% |
| 2020 | $299.20 B | 8.27% |
| 2019 | $276.35 B | 31.2% |
| 2018 | $210.64 B | -1.97% |
| 2017 | $214.86 B | 9.77% |
| 2016 | $195.74 B | -17.9% |
| 2015 | $238.41 B | 2.92% |
| 2014 | $231.65 B | -2.73% |
| 2013 | $238.15 B | -24.51% |
| 2012 | $315.46 B | 114.14% |
| 2011 | $147.31 B | 15.59% |
| 2010 | $127.44 B | -14.38% |
| 2009 | $148.85 B | 9.99% |
| 2008 | $135.33 B | -10.67% |
| 2007 | $151.50 B | -1.96% |
| 2006 | $154.53 B |
End of Day market cap according to different sources
On Sep 24th, 2022 the market cap of Roche was reported to be:
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $438.33 B | 69.28% | 🇺🇸 USA |
 Novartis NVS | $166.30 B | -35.77% | 🇨🇭 Switzerland |
 Pfizer PFE | $247.39 B | -4.46% | 🇺🇸 USA |
 Abbott Laboratories ABT | $176.31 B | -31.91% | 🇺🇸 USA |
 Amgen AMGN | $127.84 B | -50.63% | 🇺🇸 USA |
 Sanofi SNY | $96.51 B | -62.72% | 🇫🇷 France |
 Becton Dickinson BDX | $66.67 B | -74.25% | 🇺🇸 USA |
 Merck MRK | $219.83 B | -15.10% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $73.86 B | -71.47% | 🇬🇧 UK |